Dosing in clinical trials is meticulously monitored. Phase I trials focus on finding the maximum tolerated dose (MTD) without causing severe side effects. Phase II and III trials further refine dosing to find the optimal balance of efficacy and safety. Patients are closely monitored, and doses are adjusted as needed.
